Rasna Therapeutics
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-165.10-394.46-79.66-29.90-8.07-11.03-0.96-3.17-2.37-1.99-4.80-8.07
Price/Sales ratio
-18.88KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
1.15K-598.08-68.5517.5510.604.07-1.93-1.55-0.80-4.54-1.494.07
Price/Cash Flow ratio
-165.20-511.17-432.59-44.73-12.52-111.59-20.56-14.09-4.34-1.04K-11.28-12.52
Price/Free Cash Flow ratio
-165.20-511.17-432.59-44.57-12.50-111.59-20.56-14.09-4.34-1.04K-11.28-12.50
Price/Earnings Growth ratio
-0.696.95-0.30-0.020.430.14-0.000.040.03-0.02-0.030.14
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
11438.57%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
11438.57%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
11438.57%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/A10553.18%929.02%-0.38%-0.05%0.80%0.05%-65.71%16.50%N/AN/A-0.05%
Return on Assets
-598.87%-4352.46%-24025.86%-48.83%-78.01%-18.93%-16229.57%-2918.52%-672.25%-4644.23%-927.43%-18.93%
Return On Equity
-701.75%151.61%86.05%-58.71%-131.25%-36.90%199.89%48.85%33.94%227.13%30.27%-131.25%
Return on Capital Employed
-701.75%151.61%86.05%-60.05%-130.61%-36.02%202.97%9.30%-8.83%216.69%-5.83%-130.61%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.02N/A
Quick Ratio
6.460.000.002.740.160.030.010.020.070.040.020.03
Cash ratio
6.460.000.002.640.020.020.000.000.020.030.020.02
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/A-1.50K-166.98-39.20KN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/A57.83K54.36K90.80K212.55K1.04MN/AN/AN/A90.80K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/A33.04N/A0.020.0515.8413.282.572.2030.870.02
Debt Equity Ratio
N/AN/A-0.11N/A0.040.10-0.19-0.22-0.13-0.10-1.030.10
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/A-0.05N/A-0.05N/A
Total Debt to Capitalization
N/AN/A-0.13N/A0.040.09-0.24-0.28-0.14-0.12-0.080.09
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.10N/A
Cash Flow to Debt Ratio
N/AN/A-1.33N/A-19.14-0.34-0.48-0.49-1.42-0.04-1.71-19.14
Company Equity Multiplier
1.17-0.03-0.001.201.681.94-0.01-0.01-0.05-0.04-0.031.94
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
114.31N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1111.001.001111111
Cash Flow Coverage Ratio
N/AN/A-1.33N/A-19.14-0.34-0.48-0.49-1.42-0.04-1.71-19.14
Short Term Coverage Ratio
N/AN/A-1.33N/A-19.14-0.34-0.48-0.49-2.44-0.04-5.44-19.14
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A